US Patent 7390908 Compounds effecting glucokinase
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Clifford David Jones0
Craig Johnstone0
Darren McKerrecher0
Michael Howard Block0
Peter William Rodney Caulkett0
Rodney Brian Hargreaves0
Roger James0
Scott Boyd0
Suzanne Saxon Bowker0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+333 characters)
Article
Patent abstract
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07390908 Compounds effecting glucokinase US Patent 7390908 Compounds effecting glucokinase
Infobox
Patent Number
073909080
Patent Number
73909080
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073909080
Date of Patent
June 24, 2008
0Patent Application Number
104864960
Date Filed
August 15, 2002
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07390908 Compounds effecting glucokinase
Infobox
Is a
Patent jurisdiction
Patent number
07390908
Date of patent
June 24, 2008
Patent application number
10486496
Date Filed
August 15, 2002
Patent primary examiner
Find more entities like US Patent 7390908 Compounds effecting glucokinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.